List of human disease case fatality rates
Human
infection fatality rate
(IFR), the estimated proportion of people infected by a disease-causing agent, including asymptomatic and undiagnosed infections, who die from the disease. IFR cannot be higher than the CFR and is often much lower, but is also much harder to calculate. This data is based on optimally treated patients and exclude isolated cases or minor outbreaks, unless otherwise indicated.
Disease | Type | Treatment stage[clarification needed] | CFR | Notes | Reference(s) |
---|---|---|---|---|---|
Transmissible spongiform encephalopathy | Prion | No treatment and no cure[1] | 100%[2] | Includes Creutzfeldt–Jakob disease and all its variants, fatal insomnia, kuru, Gerstmann–Sträussler–Scheinker syndrome, Variably protease-sensitive prionopathy and others. | [3] No cases of survival, invariably fatal. |
Rabies | Viral | Unvaccinated | ≈100%[4] | Preventable with vaccine and a medically induced coma, however this protocol has since been disputed.[6]
|
29 known cases of survival |
Plague, pneumonic | Bacterial | Unvaccinated and untreated | ≈100% | [7]: 58 | |
African trypanosomiasis | Parasitic (protozoan) | Untreated | >99% | Without treatment this disease is nearly invariably fatal due to its parasitic and extremely debilitating nature[8] | [9] |
Visceral leishmaniasis | Parasitic (protozoan) | Untreated | >99% | [10] | |
Naegleriasis | Amoebic | Untreated | ≈98.5% | From 1962 to 2022 there have been 157 recorded cases of the infection in United States, only 4 of those 157 individuals survived the disease. A combination of drugs have shown effectiveness in survivors. | [11] |
Glanders, septicemic | Bacterial | Untreated | 95% | The rate drops significantly to >50% with treatment. | [12] |
Variola major – specifically the malignant (flat) or hemorrhagic type
|
Viral | Untreated | ≈95% | The rate dropped significantly to 10% with effective treatments. Eradicated. |
[7]: 28 [13] |
Granulomatous amoebic encephalitis | Amoebic | No cure[14] | 90% | 150 cases worldwide, only < 10 survivors have been identified. | [15][16] |
HIV/AIDS | Viral | Untreated | 90% | [17]: 1 | |
Anthrax, pulmonary
|
Bacterial | Unvaccinated and untreated | > 85% | Early treatments lower the CFR to 45% as seen in the 2001 ) could lower this further. | [7]: 88 |
Lujo virus | Viral | 80% | |||
B virus | Viral | Untreated | ≈80% | Early treatment including aciclovir can improve prognosis. | [18] |
Aspergillosis, invasive pulmonary form | Fungal | Opportunistic w/COPD, Tuberculosis and Immuno- compromised |
[50–90]% | [19] | |
Smallpox, Variola major – in pregnant women | Viral | Unvaccinated | > 65% | Eradicated. | [7]: 88 |
Influenza A virus subtype H5N1 | Viral | ≈53% | [20] | ||
Mucormycosis (Black fungus) | Fungal | [40–80]% | [21] | ||
Tularemia, pneumonic | Bacterial | Untreated | ≤ 60% | [7]: 78 | |
Ebola – specifically EBOV | Viral | Unvaccinated and untreated | [25–90]% | Prognosis improved by early supportive treatments as seen in the West African epidemic and the Kivu outbreak. | [22][23] |
Marburg virus disease – all outbreaks combined | Viral | Untreated | [23–90]% | 23% in 1967 when it was first identified and 90% in 2004-2005 when the worst outbreak of the disease occurred. Galidesivir has shown promise in treating Filoviridae | [24][25] |
Cryptococcal meningitis
|
Fungal | Co-infection with HIV | [40–60]% | 6 month mortality is >=60% with fluconazole-based therapy and 40% with amphotericin-based therapy in research studies in low and middle income countries. | [26] |
Anthrax, gastrointestinal
|
Bacterial | Unvaccinated and untreated | > 50% | [7]: 27 | |
Tetanus, Generalized | Bacterial | Unvaccinated and untreated | 50% | CFR drops to [10–20]% with effective treatment. | [27] |
Tuberculosis, HIV Negative | Bacterial | Vaccinated | 43% | Vaccines have been developed but have been frequently dismissed for having received controversial and improper testing on African populations. | [28] |
Plague, septicemic | Bacterial | Unvaccinated and untreated | [30–50]% | [7]: 58 | |
Baylisascariasis
|
Parasitic (helminthous) | ≈40% | With occurrence of Neural Larva Migrans; early, aggressive treatment necessary for survival, but only 2 full recoveries from NLM ever documented | [29] | |
Hantavirus infection
|
Viral | 36% | Ribavirin may be a drug for HPS and HFRS but its effectiveness remains unknown, still, spontaneous recovery is possible with supportive treatment. | ||
Middle Eastern Respiratory Syndrome (MERS)
|
Viral | 34% | Galidesivir has shown promise in treating Coronaviridae | [30] | |
Eastern equine encephalitis | Viral | ≈33% | [31] | ||
Bubonic plague | Bacterial | Unvaccinated and untreated | [5–60]% | [7]: 57 | |
Anthrax, gastrointestinal, oropharyngeal type | Bacterial | [10–50]% | [7]: 27 | ||
Smallpox, Variola major | Viral | Unvaccinated | 30% | [7]: 88 | |
Varicella (chickenpox), in newborns | Viral | Untreated | ≈30% | Where the mothers develop the disease between 5 days prior to, or 2 days after delivery. | [17]: 110 |
Dengue haemorrhagic fever (DHF) | Viral | Untreated | 26% | Dengue haemorrhagic fever is also known as severe dengue.[32] | [33] |
Murray Valley encephalitis (MVE) | Viral | No cure | [15–30]% | No specific treatment; usually involves supportive care. | [34] |
Hantavirus pulmonary syndrome (HPS) | Viral | Untreated | ≈21% | Galidesivir has shown promise in treating Bunyavirales | [35] |
Tularemia, typhoidal | Bacterial | Untreated | [3–35]% | [7]: 77 | |
Leptospirosis | Bacterial | <[5–30]% | [17]: 352 | ||
Meningococcal disease | Bacterial | Unvaccinated and untreated | [10–20]% | [36] | |
Typhoid fever | Bacterial | Unvaccinated and untreated | [10–20]% | [17]: 665 | |
Legionellosis | Bacterial | ≈15% | [17]: 665 | ||
Severe acute respiratory syndrome (SARS) | Viral | 11% | Galidesivir has shown promise in treating Coronaviridae. | [37] | |
Intestinal capillariasis | Parasitic (helminthous) | Untreated | ≈10% | [38] | |
Visceral leishmaniasis | Parasitic (protozoan) | ≈10% | [39] | ||
Botulism | Bacterial toxin | Treated | < 10% | Untreated foodborne botulism is thought to be ≈50% | [40] |
Diphtheria, respiratory | Bacterial | Unvaccinated and untreated | ≈[5-10]% | [41] | |
Yellow fever | Viral | Unvaccinated | 7.5% | [42] | |
Pertussis (whooping cough), infants in developing countries | Bacterial | Unvaccinated | ≈3.7% | [17]: 456 | |
Variola major
|
Viral | Vaccinated | 3% | [7]: 88 | |
Cholera, in Africa | Bacterial | ≈[2–3]% | With proper treatment, may be less than 1%, while without treatment may reach 50% | [43][44][45][46][47] | |
1918 (Spanish) flu | Viral | Treated | [2.5-9.7]% | varies with population, up to 22% in Western Samoa
|
[48][49][50] |
Angiostrongyliasis | Parasitic (helminthous) | ≈2.4% | From Hawaiian cases. | [51] | |
Measles (rubeola), in developing countries | Viral | Unvaccinated | ≈[1–3]% | May reach [10–30]% in some localities. | [17]: 431 |
Brucellosis | Bacterial | Untreated | ≤ 2% | [17]: 87 | |
Hepatitis A, adults > 50 years old | Viral | Unvaccinated | ≈1.8% | [17]: 278 | |
Coronavirus disease 2019 (COVID-19)
|
Viral | Unvaccinated & Treated with unspecific treatments |
0.5-1% | Depends largely on the age group of the person.[52] | [53] |
Lassa fever | Viral | Treated | ≈1% | 15% in hospitalized patients; higher in some epidemics. | [54] |
Mumps encephalitis | Viral | Unvaccinated | ≈1% | [17]: 431 | |
Pertussis (whooping cough), children in developing countries | Bacterial | Unvaccinated | ≈1% | For children 1–4 years old. | [17]: 456 |
Variola minor
|
Viral | Unvaccinated | 1% | [7]: 87–88 | |
Venezuelan Equine Encephalitis (VEE) | Viral | < 1% | [7]: 97–98 | ||
Anthrax, cutaneous
|
Bacterial | < 1% | [7]: 27 | ||
Seasonal Influenza, Worldwide | Viral | Largely unvaccinated, Treated |
< 0.1–0.5%[failed verification] | Depends largely on the age group of the people. | [55] |
Malaria | Parasitic (protozoan) | ≈0.3% | [56] | ||
Hepatitis A | Viral | Unvaccinated | [0.1–0.3]% | [17]: 278 | |
Polio | Viral | Without artificial breathing support | ≈0.1%, varies by age: 2-5% for children and up to 15-30% for adults | 0.5% of all infected become paralysed. Of those, about [10–20]% die. | [57][58] |
Asian (1956–58) flu | Viral | ≈0.1% | [59] | ||
Hong Kong (1968–69) flu | Viral | ≈0.1% | [59] | ||
Influenza A, typical pandemics | Viral | < 0.1% | [48] | ||
Varicella (chickenpox) , adults
|
Viral | Unvaccinated | 0.02% | [17]: 110 | |
Hand, foot and mouth disease , children < 5 years old
|
Viral | 0.01% | [60] | ||
Varicella (chickenpox) , children
|
Viral | Unvaccinated | 0.001% | [17]: 110 |
See also
- Lists of diseases
- List of infectious diseases
- List of causes of death by rate
- List of notifiable diseases – diseases that should be reported to public health officials.
References
- ^ "Creutzfeldt-Jakob Disease (CJD): Symptoms & Treatment". Cleveland Clinic. Retrieved 2024-03-05.
- ^ Weiss, Cynthia (27 June 2021). "Sharing Mayo Clinic: Back from the brink and overcoming a rare neurologic disorder". Mayo Clinic News Network. Retrieved 8 January 2023.
- PMID 31943194.
- CBS news. 2 April 2020. Archivedfrom the original on 2021-03-12. Retrieved 2021-03-18.
- ^ "Is Rabies Really 100% Fatal? | Viruses101 | Learn Science at Scitable". www.nature.com. Retrieved 2023-08-17.
- PMID 27730539.
- ^ ISBN 9780160900150. Archived from the original(PDF) on 2015-02-09. Retrieved 2012-08-01.
- ^ "CDC - African Trypanosomiasis - General Information - East African Trypanosomiasis FAQs". www.cdc.gov. 2019-04-22. Retrieved 2023-08-17.
- Seattle Biomed. 2014. Archived from the originalon 2014-06-07. Retrieved 2014-06-04.
- ^ World Health Organization, (2013) "Health Topics: Leishmaniasis." Archived 2016-11-22 at the Wayback Machine
- ^ "General Information | Naegleria fowleri". CDC. 2023-05-03. Retrieved 2023-07-11.
- ^ "Department of Agriculture | Glanders". www.nj.gov. Retrieved 2023-09-06.
- ^ "Smallpox Disease and Its Clinical Management" (PDF). From the training course titled "Smallpox: Disease, Prevention, and Intervention" (www.bt.cdc.gov/agent/smallpox/training/overview). Archived from the original (PDF) on 2016-05-10. Retrieved 2007-12-26.
- S2CID 28069984.
- PMID 22869634.
- PMID 32603318.
- ^ ISBN 978-0-87553-189-2.
- ISBN 978-1-4665-5396-5. Archivedfrom the original on 2021-09-26. Retrieved 2020-05-15.
- PMID 21881144.
- ^ "Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2021". World Health Organization. Retrieved January 3, 2023.
- ^ "Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium" (PDF). European Confederation of Medical Mycology. 4 November 2019. Archived (PDF) from the original on 2 March 2021. Retrieved 31 May 2021.
- ^ "Ebola virus disease Fact sheet N°103". World Health Organization. March 2014. Archived from the original on 14 December 2014. Retrieved 12 April 2014.
- ISBN 978-0-08057-548-3. Archivedfrom the original on 2020-08-01. Retrieved 2017-09-03.
- PMID 5748997.
- PMID 16038348.
- PMID 23055838.
- ^ Hinfey, Patrick B (Jan 18, 2019). "What is the mortality rate for tetanus (lockjaw)?". Medscape. Archived from the original on August 14, 2019. Retrieved August 14, 2019.
- PMID 21483732.
- doi:10.3133/cir1412. Archivedfrom the original on 2018-03-22. Retrieved 2018-03-21.
- ^ "MERS situation update". WHO Regional Office for the Eastern Mediterranean. April 2021. Archived from the original on 29 July 2019. Retrieved 31 May 2021.
- ^ "Eastern Equine Encephalitis | Eastern Equine Encephalitis | CDC". www.cdc.gov. 2023-06-14. Retrieved 2023-09-06.
- ^ "Dengue and severe dengue". World Health Organization. Fact sheet N°117. March 2014. Archived from the original on 2016-09-02. Retrieved 2014-08-08.
- S2CID 10135251.
- PMID 28098530.
- S2CID 73484756.
- S2CID 54396333.
- ^ "Consensus document on the epidemiology of severe acute respiratory syndrome (SARS)" (PDF). Department of Communicable Disease Surveillance and Response. World Health Organization. 2003. p. 10. Archived (PDF) from the original on 2020-01-29. Retrieved 2020-10-05.
- ^ Bernstein D. "Intestinal Parasite Infections From Roundworms – Description, Diagnosis, Treatment". Fungus Focus. Archived from the original on 2016-03-04. Retrieved 2013-03-29.
- ^ "Initiative for Vaccine Research (IVR): Parasitic Diseases – Leishmaniasis". World Health Organization. 2013. Archived from the original on March 22, 2006.
- S2CID 23705912.
- ^ Centers for Disease Control and Prevention, (7 February 2011) "Diphtheria." Archived 2016-04-12 at the Wayback Machine
- ^ "Yellow fever". Fact sheets. World Health Organization. 7 May 2019. Archived from the original on 19 February 2014. Retrieved 5 October 2020.
- PMID 30606126.
- PMID 24916870.
- PMID 28797285.
- PMID 30715523.
- S2CID 208787765.
- ^ PMID 16494711.
- ^ Hong NH (2015). "Epidemic Analysis of 1918 Influenza in China – Research on Huolu County in Zhili Province". Historical Research in Auhui.
- ISBN 978-0-8160-6935-4. Archivedfrom the original on 1 January 2016. Retrieved 29 October 2015 – via Google Books.
- PMID 31287041.
- ^ "Estimating mortality from COVID-19". www.who.int. Retrieved 2023-09-07.
- ^ Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; MacDonald, Bobbie; Beltekian, Diana; Roser, Max (August 23, 2021). "Mortality Risk of COVID-19". Our World in Data. Archived from the original on August 24, 2021. Retrieved August 23, 2021.
- ^ "Lassa fever". World Health Organization. 31 July 2017. Archived from the original on 5 August 2012. Retrieved 31 May 2021.
- PMID 29248255.
- WHO. WHO. December 2014. Archivedfrom the original on 3 September 2014. Retrieved 14 Jan 2015.
- WHO. WHO. 22 July 2019. Archivedfrom the original on 17 October 2019. Retrieved 12 May 2020.
- ^ Hamborsky J, Kroger A, Wolfe C, eds. (2015), "Poliomyelitis", Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) (13th ed.), Washington DC: Public Health Foundation, (chap. 18), archived from the original on 30 December 2016.
- ^ S2CID 34200426.
- PMID 25117760.